Gastrointestinal Cancer News & Features
Patients with GI cancer may struggle to maintain nutritional status; therefore, nurses should be ready to step in with information and interventions.
Use of adjuvant systemic therapy for localized gastrointestinal stromal tumors has significantly increased over time and patients treated with the therapy have improved survival over surgery alone, according to study data.
Patients with bile duct cancer could be helped by a new class of experimental drug, according to a study.
Localized gastrointestinal stromal tumors (GISTs) are rarely seen, but are the most common sarcomas in the gastrointestinal tract.
Precise risk assessment for gastric and breast cancers among CDH1 gene mutation carriers may improve genetic counseling
More exacting estimates of age-associated risks of gastric and breast cancer were derived for carriers of the CDH1 gene mutation, a cancer-predisposing gene in families meeting criteria for clinically defined hereditary diffuse gastric cancer.
Gastrointestinal Cancer Clinical Trials
- Risk of thyroid cancer increases after a breast cancer diagnosis
- Childhood leukemia study reveals disease subtypes and new treatment options
- Counseling cancer patients on effective nutritional practices
- Chemotherapy before breast cancer surgery increases likelihood of breast-preserving procedure
- Effective management of dietary cholesterol may prevent metastasis in patients with prostate cancer
- Joint statement offers new recommendations for treating cardiovascular conditions
- Physicians who review patients' meds more likely to achieve health goals
- Prevalence of childhood cancer survivors increasing
- Targeted drug doubles progression-free survival in Hodgkin lymphoma
- Genetically engineered immunotoxin shows early promise for B-cell malignancies
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|